Level Up with #7Up: Bybit’s 7th Anniversary Shares a $2.5 Million Thank-You with Nearly 80 Million Traders Worldwide
DUBAI, UAE, Nov. 26, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
PAVING THE WAY FOR WOMEN’S VOICES: ENTREPRENEUR SHAILI CHOPRA SHARES HER ADVICE FOR FEMALE FOUNDERS ON THE FOUNDERMETRICS PODCAST, BY VESTD
FROM BUSINESS REPORTER TO FOUNDING A WOMEN'S MOVEMENT: SHAILI CHOPRA'S JOURNEY TO…
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS…
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract…
Jet.AIReports Third Quarter 2025 Financial Results and Shares Progress on the Third Milestone of the Canadian Hyperscale Data Center Project
LAS VEGAS, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Jet.AI. Inc. (“Jet.AI” or…
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 32 In accordance with Article 19 (3) of the…
HYUNDAI MOTOR COMPANY PRESIDENT AND CEO JOS MUOZ SHARES STRATEGIC VISION FOR 2026 AT 2025 LEADERS TALK
Hyundai Motor CEO José Muñoz emphasised resilience, adaptability, and cross-functional alignment as…
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
